Soleno Therapeutics (SLNO) News Today $52.71 -3.13 (-5.61%) (As of 11/29/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Short Interest in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Drops By 23.2%Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 4,740,000 shares, a drop of 23.2% from the October 31st total of 6,170,000 shares. Approximately 14.8% of the company's stock are short sold. Based on an average daily trading volume, of 654,000 shares, the days-to-cover ratio is presently 7.2 days.November 29 at 9:23 AM | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by Vestal Point Capital LPVestal Point Capital LP cut its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 40.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 720,000 shares of the company's stock after selliNovember 29 at 8:19 AM | marketbeat.comWhat the Options Market Tells Us About Soleno TherapeuticsNovember 27, 2024 | benzinga.comSoleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare ConferenceNovember 27, 2024 | globenewswire.comSoleno Therapeutics slides after FDA review extension of its Prader-Willi syndrome treatmentNovember 26, 2024 | seekingalpha.comSoleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi SyndromeNovember 26, 2024 | globenewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by BrokeragesShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have earned a consensus rating of "Buy" from the seven research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation and one has issued a stNovember 26, 2024 | marketbeat.comWestfield Capital Management Co. LP Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Westfield Capital Management Co. LP purchased a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 495,708 shares of the company's stocNovember 25, 2024 | marketbeat.comSoleno Therapeutics Reports Q3 Progress and FinancialsNovember 21, 2024 | markets.businessinsider.comSoleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024November 14, 2024 | globenewswire.comHere's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn SituationNovember 12, 2024 | finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Earns Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $70.00 price objective on shares of Soleno Therapeutics in a research note on Monday.November 11, 2024 | marketbeat.comPositive Outlook for Soleno Therapeutics: Buy Rating Based on Anticipated FDA Approval and Strong Cash PositionNovember 9, 2024 | markets.businessinsider.comCantor Fitzgerald Remains a Buy on Soleno Therapeutics (SLNO)November 8, 2024 | markets.businessinsider.comSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | finance.yahoo.comHarbor Capital Advisors Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Harbor Capital Advisors Inc. purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 36,048 shares of the company's stock, valued at approximately $1,82November 6, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Stock, Option ChainNovember 3, 2024 | benzinga.comEmerald Advisers LLC Increases Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Emerald Advisers LLC raised its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 6.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 313,334 shares of the company's stock after buying an additioNovember 3, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Recommendation of "Buy" by AnalystsShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been assigned a consensus rating of "Buy" from the eight ratings firms that are presently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy raNovember 1, 2024 | marketbeat.comSoleno Therapeutics price target raised to $73 from $65 at OppenheimerOctober 29, 2024 | markets.businessinsider.comSoleno Therapeutics (NASDAQ:SLNO) Hits New 12-Month High on Analyst UpgradeSoleno Therapeutics (NASDAQ:SLNO) Hits New 1-Year High on Analyst UpgradeOctober 28, 2024 | marketbeat.comSoleno Therapeutics to Participate in Upcoming November Investor ConferencesOctober 28, 2024 | tmcnet.comSoleno Therapeutics announces passing of former chairman Ernest MarioOctober 22, 2024 | markets.businessinsider.comSoleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.October 21, 2024 | markets.businessinsider.comSoleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCROctober 16, 2024 | msn.comSoleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome TreatmentOctober 16, 2024 | insidermonkey.com10 Biggest Stocks with Negative Beta to ConsiderOctober 14, 2024 | insidermonkey.comSoleno Therapeutics (NASDAQ:SLNO) Trading 6.4% Higher - Still a Buy?Soleno Therapeutics (NASDAQ:SLNO) Trading 6.4% Higher - Time to Buy?October 11, 2024 | marketbeat.comCarlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.October 10, 2024 | finance.yahoo.comSoleno Therapeutics Nears FDA Decision: Strong Buy Targeting PWS Hyperphagia TreatmentsOctober 10, 2024 | seekingalpha.comThe Manufacturers Life Insurance Company Raises Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)The Manufacturers Life Insurance Company lifted its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 120.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,408 shares of the company's stOctober 10, 2024 | marketbeat.comBelite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On OculisOctober 9, 2024 | markets.businessinsider.comSoleno Therapeutics Jumps After FDA Says No Advisory Panel Meeting Needed for Prader-Willi Syndrome DrugOctober 8, 2024 | marketwatch.comSoleno Therapeutics Says FDA Determines No Need For Advisory Committee Meeting For DCCR NDAOctober 8, 2024 | markets.businessinsider.comSoleno stock rises as NDA for lead asset doesn’t need FDA advisory meetingOctober 8, 2024 | msn.comSoleno Therapeutics's Options Frenzy: What You Need to KnowOctober 8, 2024 | benzinga.comSoleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi SyndromeOctober 8, 2024 | markets.businessinsider.comSLNO Stock Rises as Prader-Willi Treatment Nears FDA ApprovalOctober 8, 2024 | gurufocus.comWhy Soleno Therapeutics Stock Blasted 9% Higher TodayOctober 8, 2024 | fool.comSoleno Therapeutics Target of Unusually Large Options Trading (NASDAQ:SLNO)Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Stock traders bought 11,478 put options on the stock. This represents an increase of approximately 1,203% compared to the average daily volume of 881 put options.October 8, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Reaches New 1-Year High - Still a Buy?Soleno Therapeutics (NASDAQ:SLNO) Hits New 12-Month High - Here's WhyOctober 8, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by AnalystsShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been given an average rating of "Buy" by the eight brokerages that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating toOctober 7, 2024 | marketbeat.comInsider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 3,108 Shares of StockOctober 4, 2024 | insidertrades.comKristen Yen Sells 3,108 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) StockSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) insider Kristen Yen sold 3,108 shares of the company's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $49.43, for a total value of $153,628.44. Following the completion of the transaction, the insider now directly owns 81,465 shares in the company, valued at approximately $4,026,814.95. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.October 3, 2024 | marketbeat.comJanus Henderson Group PLC's Strategic Acquisition in Soleno Therapeutics IncOctober 3, 2024 | gurufocus.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Position Raised by Nantahala Capital Management LLCNantahala Capital Management LLC raised its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 27.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,082,107 shares of the company's stock after purchasing an adOctober 1, 2024 | marketbeat.comPerceptive Advisors LLC Raises Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Perceptive Advisors LLC boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 4.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,204,976 shares of the company's stock after acquirSeptember 30, 2024 | marketbeat.comNantahala Capital Management Reduces Stake in America's Car-Mart IncSeptember 24, 2024 | finance.yahoo.comSamlyn Capital LLC Purchases 282,122 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Samlyn Capital LLC lifted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 128.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 501,049 shares of the company's stock aSeptember 24, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Holdings Lifted by Avoro Capital Advisors LLCAvoro Capital Advisors LLC grew its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 28.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,091,666 shares of the companySeptember 23, 2024 | marketbeat.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Black Friday ONLY — must read! (Ad)Legendary financial forecaster, Martin Weiss just issued a chilling warning: He believes The Deep State recently gave Big Tech massive leeway to force AI on the American people … (before Trump takes office) … Click here for more details before it’s too late! SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.780.87▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼104▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Penumbra News Glaukos News Bausch + Lomb News Inspire Medical Systems News PROCEPT BioRobotics News Envista News Axonics News Inari Medical News LivaNova News Enovis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLNO Stock Alerts